Endogenous estrogens—breast cancer and chemoprevention

被引:0
|
作者
Beata Starek-Świechowicz
Bogusława Budziszewska
Andrzej Starek
机构
[1] Jagiellonian University,Department of Biochemical Toxicology, Chair of Toxicology, Medical College
[2] Polish Academy of Sciences,Department of Experimental Neuroendocrinology, Institute of Pharmacology
来源
Pharmacological Reports | 2021年 / 73卷
关键词
Breast cancer; Endogenous estrogens; Estrogen metabolism; Chemopreventive agents;
D O I
暂无
中图分类号
学科分类号
摘要
Breast cancer is the most common female malignancy and the second leading cause of cancer related deaths. It is estimated that about 40% of all cancer in women is hormonally mediated. Both estrogens and androgens play critical roles in the initiation and development of breast cancer. Estrogens influence normal physiological growth, proliferation, and differentiation of breast tissues, as well as the development and progression of breast malignancy. Breast cancer is caused by numerous endo- and exogenous risk factors. The paper presents estrogen metabolism, in particular 17β-estradiol and related hormones. The mechanisms of estrogen carcinogenesis include the participation of estrogen receptors, the genotoxic effect of the estrogen metabolites, and epigenetic processes that are also presented. The role of reactive oxygen species in breast cancer has been described. It called attention to a role of numerous signaling pathways in neoplastic transformation. Chemoprotective agents, besides other phytoestrogens, classical antioxidants, synthetic compounds, and their mechanisms of action have been shown.
引用
收藏
页码:1497 / 1512
页数:15
相关论文
共 50 条
  • [1] Endogenous estrogens-breast cancer and chemoprevention
    Starek-Swiechowicz, Beata
    Budziszewska, Boguslawa
    Starek, Andrzej
    [J]. PHARMACOLOGICAL REPORTS, 2021, 73 (06) : 1497 - 1512
  • [2] Metabolism of endogenous estrogens and breast cancer
    Coppola, Francisco
    Nader, Jose
    Aguirre, Rafael
    [J]. REVISTA MEDICA DEL URUGUAY, 2005, 21 (01): : 15 - 22
  • [3] Safer anti-estrogens used for breast cancer therapy and chemoprevention
    Shibutani, S
    Suzuki, N
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, : 170 - 170
  • [4] BREAST SIZE, ENDOGENOUS ESTROGENS, AND BREAST-CANCER - A REVIEW WITH HYPOTHESIS
    LEHRER, S
    LEVINE, E
    SONG, HK
    BLOOMER, WD
    [J]. MOUNT SINAI JOURNAL OF MEDICINE, 1988, 55 (02): : 142 - 143
  • [5] PROSPECTIVE-STUDY OF ENDOGENOUS ESTROGENS AND BREAST-CANCER
    TONIOLO, P
    LEVITZ, M
    JACQUOTTE, A
    KOENIG, K
    SHORE, R
    PASTERNACK, B
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 138 (08) : 601 - 601
  • [6] Endogenous estrogens and breast cancer risk: The case for prospective cohort studies
    Toniolo, PG
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1997, 105 : 587 - 592
  • [7] Chemoprevention of breast cancer
    Thomsen, Annelise
    Kolesar, Jill M.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (23) : 2221 - 2228
  • [8] Breast cancer chemoprevention
    Smith, SMR
    Osborne, MP
    [J]. AMERICAN JOURNAL OF SURGERY, 2000, 180 (04): : 249 - 251
  • [9] Chemoprevention of breast cancer
    Powles, TJ
    [J]. EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY - 21ST ESMO CONGRESS, EDUCATIONAL BOOK, 1996, : 115 - 117
  • [10] Breast cancer chemoprevention
    Sestak, Ivana
    Cuzick, Jack
    [J]. ONCOLOGY REVIEWS, 2008, 2 (04) : 223 - 228